PROGNOSTIC RADIOLOGY AND THE PATHOPHYSIOLOGY OF TUMORS

$5,229P41FY2010RRNIH

Ut Southwestern Medical Center, Dallas TX

Investigators

Linked publications & trials

Paper 33652703 Paper 32385936 Paper 31139498 Paper 30474153 Paper 29847586 Paper 28972888 Paper 28916775 Paper 28272754 Paper 28051774 Paper 27723138 Paper 27418237 Paper 27231848 Paper 27166971 Paper 27150735 Paper 26836042 Paper 26658971 Paper 26491014 Paper 26404723 Paper 26358902 Paper 26341673 Paper 26173637 Paper 26122548 Paper 26058575 Paper 26037136 Paper 25975847 Paper 25943328 Paper 25469992 Paper 25458842 Paper 25288790 Paper 25231025 Paper 25210979 Paper 25168480 Paper 25120071 Paper 25110966 Paper 24698945 Paper 24637963 Paper 24415759 Paper 24050192 Paper 24013159 Paper 23979260 Paper 23813468 Paper 23807909 Paper 23652627 Paper 23638013 Paper 23602729 Paper 23592268 Paper 23575743 Paper 23572519 Paper 23552448 Paper 23540575 Paper 23468384 Paper 23447121 Paper 23378821 Paper 23358651 Paper 23333571 Paper 23285128 Paper 23273841 Paper 23257920 Paper 23246650 Paper 23235149 Paper 23205273 Paper 23197572 Paper 23192863 Paper 23180883 Paper 23159449 Paper 23072752 Paper 23055299 Paper 23032685 Paper 22981137 Paper 22884585 Paper 22775397 Paper 22740186 Paper 22697373 Paper 22683290 Paper 22682223 Paper 22571288 Paper 22493093 Paper 22473634 Paper 22464218 Paper 22451442 Paper 22420507 Paper 22419606 Paper 22383401 Paper 22352428 Paper 22344876 Paper 22287162 Paper 22281806 Paper 22213371 Paper 22191000 Paper 22144023 Paper 22140438 Paper 22140269 Paper 22101431 Paper 22065779 Paper 22025712 Paper 22020775 Paper 22005577 Paper 21974998 Paper 21946227 Paper 21919088

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this research is to gain a comprehensive understanding of tumor physiology as related to tumor growth, development and response to therapy. A number of nonNMR approaches such as optical techniques are under development, However, we continue to pursue our MRI efforts related to measurement of oxygen tension and enzyme activation. Specifically, we will develop, demonstrate, and evaluate a novel approach to assessing tumor oxygenation with a view to rapid translation to the clinic. We believe it will be most pertinent to high dose hypofractionated radiotherapy in diseases such as prostate cancer. DOCENT (Dynamic Oxygen Challenge Evaluated by NMR T1 and T2*) exploits BOLD (blood oxygen level dependent) and TOLD (tissue oxygen level dependent) contrast to non-invasively detect changes in tumor oxygenation using proton MRI. We propose to develop DOCENT as a robust prognostic test to reveal tumor hypoxia. While the investigations proposed here are entirely pre-clinical, we believe they will demonstrate a strong rationale for rapid implementation in patients. Aim 1 will rigorously demonstrate the ability of DOCENT to categorize tumors as hypoxic (resistant or responsive) or oxic by comparison with 19F MR oximetry. Aim 2 will examine whether DOCENT does indeed predict response to hypofractionated radiation in subcutaneously growing prostate tumors. Aim 3 will extend studies to orthotopic prostate tumors. Aim 4 will seek to overcome therapeutic resistance of hypoxic tumors by including a radiation boost.

View original record on NIH RePORTER →